Clinical Trials Browser

Phase 1/2 × 3-fluorobenzylguanidine × Clear all

NCT02348749 2025-03-19

18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies

Phase 1/2 Completed

Neuroendocrine Tumors